DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading portal core
9 articles
Abbreviated enhanced MRI showed a stronger signal than ultrasound for finding early liver cancer in high-risk patients with cirrhosis.
Cardiac amyloidosis remains one of the diagnoses clinicians can miss, which is why a new AI model matters: it reads not only the heart image, but the patient context around it.
Teclistamab is no longer just a late-line myeloma option; phase III data push it earlier into the clinical argument.
A new analysis suggests Alzheimer’s pathology can be detected in midlife brains before dementia and before a dramatic loss of daily function.
If the personal statement once gave applicants room to stand out, generative AI has turned that space into a saturated, suspicious and harder-to-read layer of the admissions file.
BioVAT is not yet a practice-changing therapy, but it goes directly at heart failure’s hardest problem: lost myocardium that does not simply grow back.
Colon cancer screening is no longer framed only around colonoscopy and stool tests: ACS now brings newer FDA-approved molecular options, including blood tests, into its guidance.
HPV self-collection is again showing why screening logistics can matter as much as the laboratory test itself.
Investigational ecopipam reduced relapse risk versus placebo in children and adolescents with Tourette syndrome in a phase III randomized withdrawal study.
